Tau Aggregation in Alzheimer's Disease

References

• Ross CA, Poirier MA. What is the role of protein aggregation in neurodegeneration?. Nat Rev Mol Cell Biol 2005; 6:891 - 898
   PubMed Web of Science ®Google Scholar
• Arrasate M, Mitra S, Schweitzer ES, Segal MR, Finkbeiner S. Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death. Nature 2004; 431:805 - 810
   PubMed Web of Science ®Google Scholar
• Lambert MP, Barlow AK, Chromy BA, Edwards C, Freed R, Liosatos M, Morgan TE, Rozovsky I, Trommer B, Viola KL, Wals P, Zhang C, Finch CE, Krafft GA, Klein WL. Diffusible, nonfibrillar ligands derived from Abeta1 42 are potent central nervous system neurotoxins. Proc Natl Acad Sci USA 1998; 95:6448 - 6453
   PubMed Web of Science ®Google Scholar
• Buee L, Bussiere T, Buee Scherrer V, Delacourte A, Hof P R. Tau protein isoforms, phosphorylation and role in neurodegenerative disorders. Brain Res Brain Res Rev 2000; 33:95 - 130
   PubMed Web of Science ®Google Scholar
• Shen J, Kelleher RJ 3rd. The presenilin hypothesis of Alzheimer's disease: evidence for a loss of function pathogenic mechanism. Proc Natl Acad Sci USA 2007; 104:403 - 409
   PubMed Web of Science ®Google Scholar
• Trojanowski JQ, Lee VM. Pathological tau: a loss of normal function or a gain in toxicity?. Nat Neurosci 2005; 8:1136 - 1137
   PubMed Web of Science ®Google Scholar
• Braak H, Braak E. Neuropathological stageing of Alzheimer related changes. Acta Neuropathol 1991; 82:239 - 259
   PubMed Web of Science ®Google Scholar
• Gallyas F. Silver staining of Alzheimer's neuro Wbrillary changes by means of physical development. Acta Morph Acad Sci Hung 1971; 19:1 - 8
   PubMedGoogle Scholar
• Braak H, Alafuzoff I, Arzberger T, Kretzschmar H, Del Tredici K. Staging of Alzheimer disease associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol (Berl) 2006; 112:389 - 404
   PubMed Web of Science ®Google Scholar
• Biernat J, Mandelkow EM, Schroter C, Lichtenberg Kraag B, Steiner B, Berling B, Meyer H, Mercken M, Vandermeeren A, Goedert M. The switch of tau protein to an Alzheimer like state includes the phosphorylation of two serine proline motifs upstream of the microtubule binding region. EMBO J 1992; 11:1593 - 1597
   PubMed Web of Science ®Google Scholar
• Köpke E, Tung YC, Shaikh S, Alonso AC, Iqbal K, Grundke Iqbal I. J Biol Chem 1993; 268:24374 - 24380
   PubMed Web of Science ®Google Scholar
• Wischik CM, Edwards PC, Lai RY, Gertz HN, Xuereb JH, Paykel ES, Brayne C, Huppert FA, Mukaetova Ladinska EB, Mena R, et al. Quantitative analysis of tau protein in paired helical filament preparations: implications for the role of tau protein phosphorylation in PHF assembly in Alzheimer's disease. Neurobiol Aging 1995; 16:409 - 417
   PubMed Web of Science ®Google Scholar
• Han X, Jin M, Breuker K, McLafferty FW. Extending top down mass spectrometry to proteins with masses greater than 200 kilodaltons. Science 2006; 314:109 - 112
   PubMed Web of Science ®Google Scholar
• Landrieu I, Lacosse L, Leroy A, Wieruszeski JM, Trivelli X, Sillen A, Sibille N, Schwalbe H, Saxena K, Langer T, Lippens G. NMR analysis of a Tau phosphorylation pattern. J Am Chem Soc 2006; 128:3575 - 3583
   PubMed Web of Science ®Google Scholar
• Sillen A, Barbier P, Landrieu I, Lefevbre S, Wieruszeski JM, Leroy A, Peyrot V, Lippens G. NMR investigation of the interaction between the neuronal protein Tau and the microtubules. Biochemistry 2007; In press.
   PubMed Web of Science ®Google Scholar
• Baas PW, Black MM, Banker GA. Changes in microtubule polarity orientation during the development of hippocampal neurons in culture. J Cell Biol 1989; 109:3085 - 3094
   PubMedGoogle Scholar
• Gotz J, Ittner LM, Kins S. Do axonal defects in tau and amyloid precursor protein transgenic animals model axonopathy in Alzheimer's disease?. J Neurochem 2006; 98:993 - 1006
   PubMed Web of Science ®Google Scholar
• Cash AD, Aliev G, Siedlak SL, Nunomura A, Fujioka H, Zhu X, Raina AK, Vinters HV, Tabaton M, Johnson AB, Paula Barbosa M, Avila J, Jones PK, Castellani RJ, Smith MA, Perry G. Microtubule reduction in Alzheimer's disease and aging is independent of tau filament formation. Am J Pathol 2003; 162:1623 - 1627
   PubMed Web of Science ®Google Scholar
• Khatoon S, Grundke Iqbal I, Iqbal K. Brain levels of microtubule associated protein tau are elevated in Alzheimer's disease: a radioimmuno slot blot assay for nanograms of the protein. J Neurochem 1992; 59:750 - 753
   PubMed Web of Science ®Google Scholar
• Probst A, Gotz J, Wiederhold KH, Tolnay M, Mistl C, Jaton AL, Hong M, Ishihara T, Lee VM, Trojanowski JQ, Jakes R, Crowther RA, Spillantini MG, Burki K, Goedert M. Axonopathy and amyotrophy in mice transgenic for human four repeat tau protein. Acta Neuropathol (Berl) 2000; 99:469 - 481
   PubMed Web of Science ®Google Scholar
• Spittaels K, Van den Haute C, Van Dorpe J, Bruynseels K, Vandezande K, Laenen I, Geerts H, Mercken M, Sciot R, Van Lommel A, Loos R, Van Leuven F. Prominent axonopathy in the brain and spinal cord of transgenic mice overexpressing four repeat human tau protein. Am J Pathol 1999; 155:2153 - 2165
   PubMed Web of Science ®Google Scholar
• Ackmann M, Wiech H, Mandelkow E. Nonsaturable binding indicates clustering of tau on the microtubule surface in a paired helical filament like conformation. J Biol Chem 2000; 275:30335 - 30343
   PubMed Web of Science ®Google Scholar
• Le Corre S, Klafki HW, Plesnila N, Hubinger G, Obermeier A, Sahagun H, Monse B, Seneci P, Lewis J, Eriksen J, Zehr C, Yue M, McGowan E, Dickson DW, Hutton M, Roder HM. An inhibitor of tau hyper phosphorylation prevents severe motor impairments in tau transgenic mice. Proc Natl Acad Sci USA 2006; 103:9673 - 9678
   PubMed Web of Science ®Google Scholar
• Alonso AC, Zaidi T, Grundke Iqbal I, Iqbal K. Role of abnormally phosphorylated tau in the breakdown of microtubules in Alzheimer disease. Proc Natl Acad Sci USA 1994; 91:5562 - 5566
   PubMed Web of Science ®Google Scholar
• Alonso AC, Li B, Grundke Iqbal I, Iqbal K. Polymerization of hyperphosphorylated tau into filaments eliminates its inhibitory activity. Proc Natl Acad Sci USA 2006; 103:8864 - 8869
   PubMed Web of Science ®Google Scholar
• SantaCruz K, Lewis J, Spires T, Paulson J, Kotilinek L, Ingelsson M, Guimaraes A, DeTure M, Ramsden M, McGowan E, Forster C, Yue M, Orne J, Janus C, Kuskowski M, Hyman B, Hutton M, Ashe KH. Tau suppression in a neurodegenerative mouse model improves memory function. Science 2005; 309:476 - 481
   PubMed Web of Science ®Google Scholar
• Makrides V, Massie MR, Feinstein SC, Lew J. Evidence for two distinct binding sites for tau on microtubules. Proc Natl Acad Sci USA 2004; 101:6746 - 6751
   PubMed Web of Science ®Google Scholar
• Goedert M, Jakes R, Spillantini MG, Hasegawa M, Smith MJ, Crowther RA. Assembly of microtubule associated protein tau into Alzheimer like filaments induced by sulphated glycosaminoglycans. Nature 1996; 383:550 - 553
   PubMed Web of Science ®Google Scholar
• Wilson DM, Binder LI. Free fatty acids stimulate the polymerization of tau and amyloid beta peptides. In vitro evidence for a common effector of pathogenesis in Alzheimer's disease. Am J Pathol 1997; 150:2181 - 2195
   PubMed Web of Science ®Google Scholar
• Kampers T, Friedhoff P, Biernat J, Mandelkow EM, Mandelkow E. RNA stimulates aggregation of microtubule associated protein tau into Alzheimer like paired helical filaments. FEBS Lett 1996; 399:344 - 349
   PubMed Web of Science ®Google Scholar
• Novak M, Kabat J, Wischik CM. Molecular characterization of the minimal protease resistant tau unit of the Alzheimer's disease paired helical filament. EMBO J 1993; 12:365 - 370
   PubMed Web of Science ®Google Scholar
• Sillen A, Leroy A, Wieruszeski JM, Loyens A, Beauvillain JC, Buee L, Landrieu I, Lippens G. Regions of tau implicated in the paired helical fragment core as defined by NMR. Chembiochem 2005; 6:1849 - 1856
   PubMed Web of Science ®Google Scholar
• Sibille N, Sillen A, Leroy A, Wieruszeski JM, Mulloy B, Landrieu I, Lippens G. Structural impact of heparin binding to full length Tau as studied by NMR spectroscopy. Biochemistry 2006; 45:12560 - 12572
   PubMed Web of Science ®Google Scholar
• Margittai M, Langen R. Template assisted filament growth by parallel stacking of tau. Proc Natl Acad Sci USA 2004; 101:10278 - 10283
   PubMed Web of Science ®Google Scholar
• Nelson R, Sawaya MR, Balbirnie M, Madsen AO, Riekel C, Grothe R, Eisenberg D. Structure of the cross beta spine of amyloid like fibrils. Nature 2005; 435:773 - 778
   PubMed Web of Science ®Google Scholar
• Ritter C, Maddelein ML, Siemer AB, Luhrs T, Ernst M, Meier BH, Saupe SJ, Riek R. Correlation of structural elements and infectivity of the HET s prion. Nature 2005; 435:844 - 848
   PubMed Web of Science ®Google Scholar
• Tycko R. Progress towards a molecular level structural understanding of amyloid fibrils. Curr Opin Struct Biol 2004; 14:96 - 103
   PubMed Web of Science ®Google Scholar
• von Bergen M, Barghorn S, Li L, Marx A, Biernat J, Mandelkow EM, Mandelkow E. Mutations of tau protein in frontotemporal dementia promote aggregation of paired helical filaments by enhancing local beta structure. J Biol Chem 2001; 276:48165 - 48174
   PubMed Web of Science ®Google Scholar
• von Bergen M, Friedhoff P, Biernat J, Heberle J, Mandelkow EM, Mandelkow E. Assembly of tau protein into Alzheimer paired helical filaments depends on a local sequence motif ((306)VQIVYK(311)) forming beta structure. Proc Natl Acad Sci USA 2000; 97:5129 - 5134
   PubMed Web of Science ®Google Scholar
• Goedert M, Jakes R, Crowther RA. Effects of frontotemporal dementia FTDP 17 mutations on heparin induced assembly of tau filaments. FEBS Lett 1999; 450:306 - 311
   PubMed Web of Science ®Google Scholar
• Berriman J, Serpell LC, Oberg KA, Fink AL, Goedert M, Crowther RA. Tau filaments from human brain and from in vitro assembly of recombinant protein show cross beta structure. Proc Natl Acad Sci USA 2003; 100:9034 - 9038
   PubMed Web of Science ®Google Scholar
• Barghorn S, Davies P, Mandelkow E. Tau paired helical filaments from Alzheimer's disease brain and assembled in vitro are based on beta structure in the core domain. Biochemistry 2004; 43:1694 - 1703
   PubMed Web of Science ®Google Scholar
• Sadqi M, Hernandez F, Pa U, Perez M, Schaeberle MD, Avila J, Munoz V. Alpha helix structure in Alzheimer's disease aggregates of tau protein. Biochemistry 2002; 41:7150 - 7155
   PubMed Web of Science ®Google Scholar
• Kunjithapatham R, Oliva FY, Doshi U, Perez M, Avila J, Munoz V. Role for the alpha helix in aberrant protein aggregation. Biochemistry 2005; 44:149 - 156
   PubMed Web of Science ®Google Scholar
• Sillen A, Wieruszeski JM, Leroy A, Younes AB, Landrieu I, Lippens G. High resolution magic angle spinning NMR of the neuronal tau protein integrated in Alzheimer's like paired helical fragments. J Am Chem Soc 2005; 127:10138 - 10139
   PubMed Web of Science ®Google Scholar
• Alonso AC, Zaidi T, Novak M, Grundke Iqbal I, Iqbal K. Hyperphosphorylation induces self assembly of tau into tangles of paired helical filaments /straight filaments. Proc Natl Acad Sci USA 2001; 98:6923 - 6928
   PubMed Web of Science ®Google Scholar
• Shimura H, Schwartz D, Gygi SP, Kosik KS. CHIP Hsc70 complex ubiquitinates phosphorylated tau and enhances cell survival. J Biol Chem 2004; 279:4869 - 4876
   PubMed Web of Science ®Google Scholar
• Lu PJ, Wulf G, Zhou XZ, Davies P, Lu KP. The prolyl isomerase Pin1 restores the function of Alzheimer associated phosphorylated tau protein. Nature 1999; 399:784 - 788
   PubMed Web of Science ®Google Scholar
• Fulga TA, Elson Schwab I, Khurana V, Steinhilb ML, Spires TL, Hyman BT, Feany MB. Abnormal bundling and accumulation of F actin mediates tau induced neuronal degeneration in vivo. Nat Cell Biol 2007; 9:139 - 148
   PubMed Web of Science ®Google Scholar